Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

User Fee Waivers For Small Businesses Might Get Smaller Under PDUFA V

Executive Summary

FDA wants to tighten its eligibility restrictions for small business waivers of user fees, but industry does not appear interested in changing the rules, even if it would hold down costs for other applicants.
Advertisement

Related Content

PDUFA Formula Could Better Incorporate Present Economic Conditions
PDUFA Formula Could Better Incorporate Present Economic Conditions
PDUFA V: FDA Relaxes Pre-Submission Meeting Requirement
PDUFA V: FDA Relaxes Pre-Submission Meeting Requirement
Pharma Industry "Well Positioned" In Current Budget Debate, Avalere's Mendelson Suggests
PDUFA V Agreement Set In Four Areas, But Broad FDA/Industry Talks Continue
User Fee Inflation Calculations May Need To Change Due To Slow Economic Recovery
FDA Expects Sharp Drop In Drug Applications This Year

Topics

Advertisement
UsernamePublicRestriction

Register

PS053217

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel